High Priced Drugs America’s PBMs are the only member of the prescription drug supply and payment chain working to reduce high drug costs, improve patient access, and increase affordability. PBMs administer prescription drug plans for more than 266 million Americans
PCMA Launches New Campaign Aimed at Repealing the Medicare Prescription Drug Rebate Rule March 1, 2021 ARTICLE (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) unveiled a new campaign commending the Biden Administration for delaying the Medicare prescription drug
Chief Executive Officer, Optum Rx Heather Cianfrocco was named as chief executive officer of Optum Rx®, an industry-leading provider of pharmacy care services, in April 2021. In this role, Cianfrocco drives efforts to advance whole-person health through a unique, synchronized
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s announcement on 2021 Medicare Part D premiums. “PCMA applauds the Administration for its work continuing the success of the Part D
According to a new analysis, there are now 70 PBMs operating in a diverse and competitive marketplace.
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
It seems that some have been tossing around the word fact lately when they really mean opinion. Facts are things that we have real evidence to support, not simply statements we want to be true. PBMs work to provide patients
With a nod to Dickens given that it’s the holidays, I’ve been thinking about biosimilars past, present and future lately. In that holiday spirit, even though the parallels aren’t perfect to the classic holiday story, let’s look at the biosimilar
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released the following statement on the Congressional Budget Office’s (CBO) estimate that The INSULIN Act will increase taxpayer spending by approximately $23 billion over 10 years. Pharmacy benefit managers, PBMs,
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription
©2024 PCMA. All Rights Reserved.
